Movement Alert｜Duality Biotherapeutics-B Falls 5.59% in Regular Trading, Continued Correction From Highs Despite Recent Positive Catalysts

Market Focus

Yesterday

On June 1, Duality Biotherapeutics-B fell 5.59% in regular trading, trading at 212.6 HKD/share, with trading volume of HKD 155 million.

The stock has now retreated approximately 60% from its September high. Despite multiple recent positive developments — including a global Phase III first patient dosing for DB-1311/BNT324 in partnership with BioNTech, share buybacks totaling over HKD 26 million across several sessions in late May, and institutional accumulation by LAV Asset Management increasing its stake to 13.00% — selling pressure has persisted amid broader sector weakness.

Within the Biotechnology sector, performance was mixed. Among individual stocks, AKESO rose 2.46%, 3SBIO gained 0.65%, while INNOVENT BIO fell 2.58%, BEIGENE declined 2.55%, and SKB BIO dropped 3.33%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1137514104"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137514104\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137514104?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 11:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137514104","market":"us","top_or_hot":-1,"title":"Movement Alert｜Duality Biotherapeutics-B Falls 5.59% in Regular Trading, Continued Correction From Highs Despite Recent Positive Catalysts","media":"Market Focus","content":"<p><p>On June 1, Duality Biotherapeutics-B fell 5.59% in regular trading, trading at 212.6 HKD/share, with trading volume of HKD 155 million.</p><p>The stock has now retreated approximately 60% from its September high. Despite multiple recent positive developments — including a global Phase III first patient dosing for DB-1311/BNT324 in partnership with BioNTech, share buybacks totaling over HKD 26 million across several sessions in late May, and institutional accumulation by LAV Asset Management increasing its stake to 13.00% — selling pressure has persisted amid broader sector weakness.</p><p>Within the Biotechnology sector, performance was mixed. Among individual stocks, AKESO rose 2.46%, 3SBIO gained 0.65%, while INNOVENT BIO fell 2.58%, BEIGENE declined 2.55%, and SKB BIO dropped 3.33%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Duality Biotherapeutics-B Falls 5.59% in Regular Trading, Continued Correction From Highs Despite Recent Positive Catalysts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Duality Biotherapeutics-B Falls 5.59% in Regular Trading, Continued Correction From Highs Despite Recent Positive Catalysts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-01 11:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 1, Duality Biotherapeutics-B fell 5.59% in regular trading, trading at 212.6 HKD/share, with trading volume of HKD 155 million.</p><p>The stock has now retreated approximately 60% from its September high. Despite multiple recent positive developments — including a global Phase III first patient dosing for DB-1311/BNT324 in partnership with BioNTech, share buybacks totaling over HKD 26 million across several sessions in late May, and institutional accumulation by LAV Asset Management increasing its stake to 13.00% — selling pressure has persisted amid broader sector weakness.</p><p>Within the Biotechnology sector, performance was mixed. Among individual stocks, AKESO rose 2.46%, 3SBIO gained 0.65%, while INNOVENT BIO fell 2.58%, BEIGENE declined 2.55%, and SKB BIO dropped 3.33%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1137514104","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137514104","pubTimestamp":1780283369,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 1, Duality Biotherapeutics-B fell 5.59% in regular trading, trading at 212.6 HKD/share, with trading volume of HKD 155 million.The stock has now retreated approximately 60% from its September...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"走势警报|Duality Biotherapeutics-B常规交易下跌5.59%，尽管近期有积极催化剂，但仍从高位持续回调","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"On June 1, Duality Biotherapeutics-B fell 5.59% in regular trading, trading at 212.6 HKD/share, with trading volume of HKD 155 million.The stock has now retreated approximately 60% from its September high. Despite multiple recent positive developments — including a global Phase III first patient dosing for DB-1311/BNT324 in partnership with BioNTech, share buybacks totaling over HKD 26 million across several sessions in late May, and institutional accumulation by LAV Asset Management increasing its stake to 13.00% — selling pressure has persisted amid broader sector weakness.Within the Biotechnology sector, performance was mixed. Among individual stocks, AKESO rose 2.46%, 3SBIO gained 0.65%, while INNOVENT BIO fell 2.58%, BEIGENE declined 2.55%, and SKB BIO dropped 3.33%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}